Cited by 376Regulation of Appetite and ObesityNeuropeptides and Animal PhysiologyGrowth Hormone and Insulin-like Growth Factors

LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

Open access
Ge, Xuecai, Yang, Hong, Bednarek, Maria A., Galon-Tilleman, Hadas, Chen, Peirong, Chen, Michael, Lichtman, Joshua S., Wang, Yan +8 more·2018·Cell Metabolism

Abstract

Ghrelin, an appetite-stimulatory hormone secreted by the stomach, was discovered as a ligand for the growth hormone secretagogue receptor (GHSR). Through GHSR, ghrelin stimulates growth hormone (GH) secretion, a function that evolved to protect against starvation-induced hypoglycemia. Though the biology mediated by ghrelin has been described in great detail, regulation of ghrelin action is poorly understood. Here, we report the discovery of liver-expressed antimicrobial peptide 2 (LEAP2) as an endogenous antagonist of GHSR. LEAP2 is produced in the liver and small intestine, and its secretion is suppressed by fasting. LEAP2 fully inhibits GHSR activation by ghrelin and blocks the major effects of ghrelin in vivo, including food intake, GH release, and maintenance of viable glucose levels during chronic caloric restriction. In contrast, neutralizing antibodies that block endogenous LEAP2 function enhance ghrelin action in vivo. Our findings reveal a mechanism for fine-tuning ghrelin action in response to changing environmental conditions.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2017.10.016

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LEAP2 is an endogenous antagonist of the ghrelin receptor, or growth hormone secretagogue receptor (GHSR).

    “Importantly, LEAP2 was reported to be an endogenous antagonist of the ghrelin receptor, or growth hormone secretagogue receptor (GHSR).”
  • LEAP2 can fully blunt GHSR activation by ghrelin, thus reducing food intake and growth hormone release.

    “Indeed, LEAP2 can fully blunt GHSR activation by ghrelin, thus reducing food intake and growth hormone (GH) release 47.”
  • Comparing RNA sequencing of jejunum and stomach between sham and gastric sleeve bypass allowed the identification of LEAP2, an endogenous antagonist of the ghrelin receptor, which may contribute to the efficiency of gastric bypass.

    “Comparing RNA sequencing of jejunum and stomach when comparing sham and gastric sleeve bypass allowed the identification of LEAP2, an endogenous antagonist of the ghrelin receptor, which may contribute to the efficiency of gastric bypass 47.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ge, X., Yang, H., Bednarek, M. A., Galon-Tilleman, H., Chen, P., Chen, M., Lichtman, J. S., Wang, Y., Dalmas, O., Yin, Y., Tian, H., Jermutus, L., Grimsby, J., Rondinone, C. M., Konkar, A., & Kaplan, D. D.
Affiliations
NGM Biopharmaceuticals (United States) (US)
Corresponding author
  • Ge, Xuecai
  • Kaplan, Daniel D.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2018-02
Volume
27
Issue
2
Pages
461-469.e6
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2774279346
Cited by
376
References
42
Citations by year
2026: 47 · 2025: 53 · 2024: 54 · 2023: 47 · 2022: 49 · 2021: 49 · 2020: 30 · 2019: 34 · 2018: 12
FWCI
12.74
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
LEAP2, ghrelin, growth hormone secretagogue receptor, appetite regulation, dietary intake, growth hormone secretion, fasting, caloric restriction, hypoglycemia, liver, small intestine, antimicrobial peptides, neutralizing antibodies
MeSH terms
Animals, Eating, Fasting, Female, Humans, Intestine, Small, Liver, Male, Protein Binding, Growth Hormone, Caloric Restriction, Bariatric Surgery, Mice, Rats, Ghrelin, Receptors, Ghrelin, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review